D-1210-2018 Class II Terminated

Recalled by Noven Pharmaceuticals, Inc. — Miami, FL

FDA drug recall D-1210-2018 was initiated by Noven Pharmaceuticals, Inc. on Sep 7, 2018 and is designated Class II. Reason for recall: Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches. The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 74908 boxes of 8 patches.

Recall details

Product Type
Drugs
Report Date
Oct 3, 2018
Initiation Date
Sep 7, 2018
Termination Date
Sep 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
74908 boxes of 8 patches

Product description

Minivelle (estradiol transdermal system) Patches, Delivers 0.075 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6675-8

Reason for recall

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Distribution pattern

Nationwide

Code information

Lots: 82599 Exp. 05/2019; 82660 Exp. 03/2019; 83396 Exp. 09/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1210-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1210-2018. Report a data issue: hello@regdatalab.com.